Skip to main content
. 2020 Sep 9;10(9):e040951. doi: 10.1136/bmjopen-2020-040951

Table 1.

Participant characteristics

Asthma n=7975 (% (n)) Chronic respiratory disease (non-asthma) n=1541 (% (n))
Age group (years)
 17 and under 5.54 (439) 0.33 (5)
 18–29 12.11 (959) 0.59 (9)
 30–39 24.68 (1955) 1.90 (29)
 40–49 30.60 (2424) 8.93 (136)
 50–59 18.67 (1479) 21.47 (327)
 60–69 6.26 (496) 37.82 (576)
 70–79 1.94 (154) 25.21 (384)
 80 and above 0.19 (15) 3.74 (57)
 Gender (% female) 82.92 (6562) 74.67 (1141)
Country
 England 75.35 (5981) 83.33 (1275)
 Scotland 13.03 (1034) 9.54 (146)
 Wales 7.19 (571) 5.23 (80)
 Northern Ireland 4.43 (352) 1.90 (29)
Influenza immunisation 2019/2020
 Yes 77.10 (6139) 89.96 (1380)
 No 22.54 (1795) 9.97 (153)
 Don’t know 0.35 (28) 0.07 (1)
Current smoking
 Non-smoker 89.41 (7115) 86.07 (1322)
 Smoker 10.59 (843) 13.93 (214)
Of smokers
 Intending to quit smoking due to COVID-19 49.11 (414) 64.48 (138)
 Not intending quit smoking due to COVID-19 50.89 (429) 35.51 (76)
Shielding
 Actively shielding 68.66 (5461) 89.97 (1381)
 Not actively shielding 31.34 (2493) 10.30 (154)
Self-isolating
 Currently self-isolating 67.81 (5403) 88.01 (1350)
 Not currently self-isolating 32.19 (2565) 11.99 (184)
 Current COVID-19 symptoms ‘Yes’ 6.89 (549) 3.07 (47)
 Current COVID-19 symptoms ‘Not sure’ 3.99 (318) 3.78 (58)
 Following self-isolation advice due to symptoms 92.81 (800) 98.04 (100)
 Not following self-isolation advice 7.19 (62) 1.96 (2)
Diagnosis
 Asthma 83.81 (7975)
 COPD 10.12 (963)
 Bronchiectasis 3.81 (363)
 ILD 1.78 (169)
 Other 0.48 (46)

COPD, chronic obstructive pulmonary disease; ILD, interstitial lung disease.